EUVIMEDEUVIMED entdecken
Open Access

Significant Association of Matrix Metalloproteinase-9 Polymorphisms With Triple Negative Breast Cancer Risk

Chih-Chiang Hung, Yun-Chi Wang, Hou-Yu Shih, Chia-Hua Liu, Jie-Long He, Jaw-Chyun Chen, Wen-Shin Chang, Chen-Hsien Su, DA-Tian Bau, Chia-Wen Tsai

Cancer Genomics - Proteomics · 2025

DOI: 10.21873/cgp.20500 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Genomics - Proteomics, 2025. Verfasst von Chih-Chiang Hung und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Breast Surgery, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C. Hauptthemen laut MEDLINE: Matrix Metalloproteinase 9, Triple Negative Breast Neoplasms, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Matrix metalloproteinase-9 (MMP-9) has been associated with the development and progression of breast cancer (BCa). However, the relationship between MMP-9 genetic variants and BCa susceptibility remains contentious and inconclusive. This study aimed to evaluate the association of MMP-9 rs3918242 promoter polymorphisms with BCa, with a particular focus on the risk of triple-negative breast cancer (TNBC). MATERIALS AND METHODS: A case-control study was conducted involving 1,232 BCa patients and 1,232 healthy controls. The MMP-9 rs3918242 genotypes were determined using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis. RESULTS: The genotype distribution of MMP-9 rs3918242 among the control group adhered to Hardy-Weinberg equilibrium (p=0.3265). No statistically significant differences were observed in the genotype frequencies between BCa cases and controls (p for trend=0.2555). Although the homozygous variant genotype (TT) showed a potential risk-increasing effect, this was not statistically significant [odds ratio (OR)=1.43, 95% confidence interval (CI)=0.88-2.36, p=0.1869]. Similarly, allele frequency analysis indicated no significant association between the variant T allele and overall BCa risk (OR=1.13, 95%CI=0.97-1.33, p=0.1265). Additionally, no interaction was detected between MMP-9 rs3918242 genotypes and the age of BCa onset (both p>0.05). Notably, the TT genotype of MMP-9 rs3918242 was significantly associated with an increased risk of TNBC (OR=2.49, 95%CI=1.32-4.72, p=0.0072). CONCLUSION: The MMP-9 rs3918242 TT genotype may serve as a potential predictive biomarker for TNBC in the Taiwanese population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Matrix Metalloproteinase 9Triple Negative Breast NeoplasmsGenetic Predisposition to DiseasePolymorphism, Single NucleotideHumansFemaleMiddle AgedCase-Control StudiesAdultGenotypeRisk FactorsAgedAllelesGene Frequency

Stichwörter der Autor:innen

Breast cancerTaiwanmatrix metalloproteinase-9polymorphismtriple negative breast cancer

Substanzen

Matrix Metalloproteinase 9MMP9 protein, human

Autor:innen und Institutionen

  • Division of Breast Surgery, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
  • Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.
  • Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.
  • Department of Post-Baccalaureate Veterinary Medicine, Asia University, Taichung, Taiwan, R.O.C.
  • Department of Medicinal Botanicals and Foods on Health Applications, Da-Yeh University, Changhua, Taiwan, R.O.C.
  • Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.; 013280@tool.caaumed.org.tw 017891@tool.caaumed.org.tw.

Zitieren

APA

Hung, C. C., Wang, Y. C., Shih, H. Y., Liu, C. H., He, J. L., Chen, J. C., Chang, W. S., Su, C. H., Bau, D. T., & Tsai, C. W. (2025). Significant Association of Matrix Metalloproteinase-9 Polymorphisms With Triple Negative Breast Cancer Risk. Cancer Genomics - Proteomics. https://doi.org/10.21873/cgp.20500

Vancouver

Hung CC, Wang YC, Shih HY, Liu CH, He JL, Chen JC, et al. Significant Association of Matrix Metalloproteinase-9 Polymorphisms With Triple Negative Breast Cancer Risk. Cancer Genomics - Proteomics. 2025. doi:10.21873/cgp.20500

BibTeX
@article{Hung2025,
  author = {Hung, Chih-Chiang and Wang, Yun-Chi and Shih, Hou-Yu and Liu, Chia-Hua and He, Jie-Long and Chen, Jaw-Chyun and Chang, Wen-Shin and Su, Chen-Hsien and Bau, DA-Tian and Tsai, Chia-Wen},
  title = {Significant Association of Matrix Metalloproteinase-9 Polymorphisms With Triple Negative Breast Cancer Risk},
  journal = {Cancer Genomics - Proteomics},
  year = {2025},
  doi = {10.21873/cgp.20500}
}
Kostenlos starten →